Physician profile
Bret D Borchelt
NPI 1871579870
$1,542.96
in general payments reported to CMS, 2019-2025
9 companies · $27.57 in 2025
The $27.57 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $34.42 · 2021: $40.53 · 2022: $385 · 2023: $346 · 2024: $73.78 · 2025: $27.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $581.82 | 2019-2022 | |
| Atricure, INC. | $359.16 | 2022-2024 | |
| Abiomed | $186.38 | 2019-2023 | Impella |
| Ethicon US, LLC | $158.52 | 2022-2023 | Echelon; Endopath |
| Haemonetics Corporation | $150.04 | 2023 | Teg6s Hemostasis System |
| Zimmer Biomet Holdings, INC. | $40.53 | 2021 | |
| Artivion, INC. | $27.57 | 2025 | Bioglue Surgical Adhesive, Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Lsi Solutions INC | $19.48 | 2022 | |
| Getinge USA Sales, LLC | $19.46 | 2023 | Vasoview Hemopro 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Borchelt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.